Shu-Yuan Xiao to Aged, 80 and over
This is a "connection" page, showing publications Shu-Yuan Xiao has written about Aged, 80 and over.
Connection Strength
0.530
-
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020 06; 33(6):1007-1014.
Score: 0.087
-
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020 05; 15(5):700-704.
Score: 0.086
-
Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features. Hum Pathol. 2014 Mar; 45(3):621-7.
Score: 0.056
-
Crohn enteritis-associated small bowel adenocarcinomas exhibit gastric differentiation. Hum Pathol. 2014 Feb; 45(2):359-67.
Score: 0.055
-
Gastric mucosal necrosis with vascular degeneration induced by doxycycline. Am J Surg Pathol. 2013 Feb; 37(2):259-63.
Score: 0.053
-
Reduced CD1d expression in colonic epithelium in microscopic colitis. Appl Immunohistochem Mol Morphol. 2006 Sep; 14(3):309-13.
Score: 0.034
-
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol. 2001 Oct; 159(4):1415-21.
Score: 0.024
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.023
-
Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility. Virchows Arch. 2021 Mar; 478(3):427-434.
Score: 0.022
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.021
-
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. PLoS One. 2018; 13(3):e0194234.
Score: 0.019
-
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 06; 8(6):696-713.
Score: 0.019
-
Safety and efficacy of EMR for sporadic, nonampullary duodenal adenomas: a single U.S. center experience (with video). Gastrointest Endosc. 2016 Oct; 84(4):700-8.
Score: 0.016
-
Smoothelin expression in the gastrointestinal tract: implication in colonic inertia. Appl Immunohistochem Mol Morphol. 2013 Oct; 21(5):452-9.
Score: 0.014